NDC 63323-322-01 - Imipenem and Cilastatin

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
63323-322
Requested NDC
63323-322-01
Package NDCs from labels
63323-322-21, 63323-322-93, 63323-322-41, 63323-322-94, 63323-322-01, 63323-322-25
Manufacturer
Fresenius Kabi USA, LLC | ACS Dobfar S.p.A. | Zambon Switzerland Ltd
Effective date
2022-10-11
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
IMIPENEM - Fresenius Kabi USA, LLC | ACS Dobfar S.p.A. | Zambon Switzerland LtdFresenius Kabi USA, LLC | ACS Dobfar S.p.A. | Zambon Switzerland Ltd2022-10-11HUMAN PRESCRIPTION DRUG LABEL
IMIPENEM - Fresenius Kabi USA, LLC | ACS Dobfar S.p.A. | Zambon Switzerland LtdFresenius Kabi USA, LLC | ACS Dobfar S.p.A. | Zambon Switzerland Ltd2022-10-10HUMAN PRESCRIPTION DRUG LABEL
IMIPENEM - Fresenius Kabi USA, LLC | ACS Dobfar S.p.A. | Zambon Switzerland LtdFresenius Kabi USA, LLC | ACS Dobfar S.p.A. | Zambon Switzerland Ltd2022-10-06HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
63323-322-01Imipenem and Cilastatin20 mL in 1 VIAL, SINGLE-DOSEINJECTION, POWDER, FOR SOLUTION2012
63323-322-25Imipenem and Cilastatin25 in 1 CARTONINJECTION, POWDER, FOR SOLUTION2512
63323-322-41Imipenem and Cilastatin20 mL in 1 VIAL, SINGLE-DOSEINJECTION, POWDER, FOR SOLUTION207
63323-322-94Imipenem and Cilastatin25 in 1 CARTONINJECTION, POWDER, FOR SOLUTION257
63323-322-21Imipenem and Cilastatin20 mL in 1 VIAL, SINGLE-DOSEINJECTION, POWDER, FOR SOLUTION205
63323-322-93Imipenem and Cilastatin25 in 1 CARTONINJECTION, POWDER, FOR SOLUTION255

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
63323-322IMIPENEM AND CILASTATIN (IMIPENEM AND CILASTATIN SODIUM) INJECTION, POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC]12Current NDC, Legacy NDC, 2 package rows20221020_6ab0ca9e-9a79-4cab-9f09-470eda06952e.zip
63323-322IMIPENEM AND CILASTATIN (IMIPENEM AND CILASTATIN SODIUM) INJECTION, POWDER, FOR SOLUTION IMIPENEM AND CILASTATIN (IMIPENEM AND CILASTATIN SODIUM) INJECTION, POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC]7Current NDC, Legacy NDC, 2 package rows20221027_0a1dd9b9-ada1-4bff-9dcb-18961254e9e8.zip
63323-322IMIPENEM AND CILASTATIN (IMIPENEM AND CILASTATIN SODIUM) INJECTION, POWDER, FOR SOLUTION IMIPENEM AND CILASTATIN (IMIPENEM AND CILASTATIN SODIUM) INJECTION, POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC]5Current NDC, Legacy NDC, 2 package rows20221103_ce771566-c4f2-447e-944a-6b908925c90b.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
63323-322-01EA - Each63323-32234deeaf8-735f-4d5d-8ce0-f7bca735d05f12022-01-06
63323-322-20EA - Each63323-32215d13752-d665-47b7-a49c-deac99c4cf1512012-07-24
63323-322-21EA - Each63323-322f295eda5-5f73-456c-93a6-9c36771eb01712022-04-06
63323-322-25EA - Each63323-3223224fb37-f888-4ac9-943f-4fd3d043976d12013-02-13
63323-322-41EA - Each63323-3221036c74b-ed3a-40f7-bbf1-87d3249cda1712022-10-06
63323-322-93EA - Each63323-32209ffc170-6c97-4df2-939c-49e83a8a41f712016-07-19
63323-322-94EA - Each63323-32289f6cade-0bdd-4c18-b4ce-d0e9ff9c765512015-01-05

DailyMed Socrata Ingredients#

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 11 of 11 · 212 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
POLYETHYLENE GLYCOL-3350 AND ELECTROLYTESPOLYETHYLENE GLYCOL-3350 AND ELECTROLYTESNovel Laboratories, Inc.29d821ff-389c-41fb-8a27-89bd3f022b822023-02-08Warnings, Adverse reactionsExact identifier
unii: 8MDF5V39QO
Omeprazole, Sodium bicarbonateOMEPRAZOLE, SODIUM BICARBONATEGuardian Drug Companye5c6c2cf-fb3b-456a-a0a0-be396d6f83192022-11-08Warnings, Adverse reactionsExact identifier
unii: 8MDF5V39QO
Imipenem and CilastatinIMIPENEM AND CILASTATIN SODIUMFresenius Kabi USA, LLCce771566-c4f2-447e-944a-6b908925c90b2022-10-11Warnings, Adverse reactionsExact identifier
application number: ANDA090577
ndc (package): 63323-322-93
ndc (package): 63323-349-21
ndc (package): 63323-349-93
ndc (package): 63323-322-21
ndc (product): 63323-349
ndc (product): 63323-322
rxcui: 1726204
spl id: 68d30458-8cd9-4fbe-9215-f36dec6c733b
spl set id: ce771566-c4f2-447e-944a-6b908925c90b
unii: 71OTZ9ZE0A
unii: 5428WXZ74M
Imipenem and CilastatinIMIPENEM AND CILASTATIN SODIUMFresenius Kabi USA, LLC0a1dd9b9-ada1-4bff-9dcb-18961254e9e82022-10-10Warnings, Adverse reactionsExact identifier
application number: ANDA090577
ndc (package): 63323-349-94
ndc (package): 63323-349-41
ndc (package): 63323-322-94
ndc (package): 63323-322-41
ndc (product): 63323-349
ndc (product): 63323-322
rxcui: 1726204
spl id: fb64108d-9be7-4eef-9395-74c782e3a3c0
spl set id: 0a1dd9b9-ada1-4bff-9dcb-18961254e9e8
unii: 71OTZ9ZE0A
unii: 5428WXZ74M
Imipenem and CilastatinIMIPENEM AND CILASTATIN SODIUMFresenius Kabi USA, LLC6ab0ca9e-9a79-4cab-9f09-470eda06952e2022-10-06Warnings, Adverse reactionsExact identifier
application number: ANDA090577
ndc (package): 63323-322-01
ndc (package): 63323-349-25
ndc (package): 63323-322-25
ndc (package): 63323-349-01
ndc (product): 63323-349
ndc (product): 63323-322
ndc11 (package): 63323032201
rxcui: 1726204
spl id: 2bb9b6ad-8e8d-4667-b108-b57a8c16318f
spl set id: 6ab0ca9e-9a79-4cab-9f09-470eda06952e
unii: 71OTZ9ZE0A
unii: 5428WXZ74M
Sodium BicarbonateSODIUM BICARBONATEInternational Medication Systems, Limited77698221-a01d-4568-a7bc-d3d4e982875d2021-12-15Warnings, Adverse reactionsExact identifier
unii: 8MDF5V39QO
8.4% SODIUM BICARBONATE8.4% SODIUM BICARBONATEHF Acquisition Co. LLC, DBA HealthFirst74d8bb7a-9e7a-105f-e053-2a91aa0aec922021-05-03Warnings, Adverse reactionsExact identifier
unii: 8MDF5V39QO
SODIUM BICARBONATESODIUM BICARBONATEMedical Purchasing Solutions, LLCbfc9c321-665c-ca97-e053-2995a90a79542021-04-12Warnings, Adverse reactionsExact identifier
unii: 8MDF5V39QO
SODIUM BICARBONATESODIUM BICARBONATEAphena Pharma Solutions - Tennessee, LLC15605a6d-6c90-47d5-9d1f-f66a3f27d5fc2017-12-13WarningsExact identifier
unii: 8MDF5V39QO
Sodium Bicarbonate AntacidSODIUM BICARBONATERichmond Pharmaceuticals, Inc.e0b2f0d3-3849-4bdf-b3d4-e14e520e36ce2017-11-01WarningsExact identifier
unii: 8MDF5V39QO
SODIUM BICARBONATESODIUM BICARBONATERichmond Pharmaceuticals, Inc.fa10d93d-b3ed-4675-a117-f573d9e72bca2017-10-30WarningsExact identifier
unii: 8MDF5V39QO
Sodium BicarbonateSODIUM BICARBONATEExela Pharma Sciences, LLCe9698a4f-1a95-4f28-a945-e8009d1d6dd42017-09-27Warnings, Adverse reactionsExact identifier
unii: 8MDF5V39QO

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.